The European Respiratory Society and the American Thoracic Society have conducted a comprehensive review of evidence of managing exacerbations of chronic obstructive pulmonary disease in order to ...
Patients with COPD exacerbations are often treated with antibiotics. There are no clear biomarkers to determine which patients will benefit from these therapies, though. A management strategy using ...
The main goals of chronic obstructive pulmonary disease (COPD) management include treatment of symptoms and prevention of exacerbations. Current guidelines recommend use of one or more long-acting ...
Artificial intelligence (AI) and natural language processing tools can build an algorithm that identifies patients with chronic obstructive pulmonary disease (COPD) at risk for exacerbations, ...
Patients with acute COPD exacerbations are seen frequently in the emergency department (ED). Acute exacerbations are associated with significant morbidity, mortality and health care expenditures.
Please provide your email address to receive an email when new articles are posted on . Exacerbation risk factors in this population included GERD, chronic bronchitis, high symptom burden and ...
Almost 16 million adults have COPD in the United States and about 3 in 4 people with this condition have at least one flare (exacerbation) a year, cites a review. But you don’t have to sit and wait ...
A health insurance claims-based risk assessment tool to predict patients’ first severe chronic obstructive pulmonary disease exacerbation has been developed and validated. Objectives: To develop and ...
The workflow encompasses patient datacollection and screening, univariate regression analysis for initial variable selection, systematic comparison of 91 machine learning models,selection and ...
The risk of a CV adverse event of special interest did decrease over time after a moderate or severe COPD exacerbation. This article is part of MPR’s coverage of the CHEST Virtual 2020 meeting. In the ...
communication features with healthcare providers. While some of these technologies also feature pulmonary rehabilitation and virtual ward components, these are not included within the scope of this ...
Cardioselective beta-blockers do not appear to increase the rate of exacerbations in patients with chronic obstructive pulmonary disease. Cardioselective beta-blockers do not appear to increase the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback